(Q61714695)
Statements
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse (English)
P Bordigoni
G Michel
H Esperou
G Souillet
T Leblanc
J L Stephan
J P Vannier
F Mechinaud
J Reiffers
E Vilmer
J Landman-Parker
M Benkerrou
A Baruchel
J Pico
F Bernaudin
C Bergeron
E Plouvier
C Thomas
J Wijdenes
B Lacour
S Blanche